Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT05623020 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 1,060 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT05623020 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 17 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05623020 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05623020 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.